B+
Bull case
25%
Probability
Target price
$29.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
WAY
WaystarCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The Q2 print showed strong revenue growth, 43% adjusted EBITDA margin, subscription expansion, and raised FY2026 guidance. AI and Iodine cross-sell could provide additional recurring growth if adoption converts into reported revenue.
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-02 · AMC.
What can break
Healthcare coverage, Medicaid enrollment, and uninsured-population changes may affect transaction volumes and provider demand [#PR-EARNINGS-2026-07-30].
Momentum
89
Value
60
Sentiment
39
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $29.00 · Bear $17.00Analysis 2026-08-03; returns require an exact persisted reference.
Earnings
2026-11-02 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $34.09
Why
Momentum89 · Δ7d +0.1
Value60 · Δ7d +0.6
Sentiment39 · Δ7d -3.2
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-02 · AMC.
- • Value remains the lead driver in the composite, 7D delta +0.6.
Contradictions & invalidation
- • Healthcare coverage, Medicaid enrollment, and uninsured-population changes may affect transaction volumes and provider demand [#PR-EARNINGS-2026-07-30].
- • Long sales cycles for larger platform deals could delay revenue recognition and weaken near-term visibility [#PR-EARNINGS-2026-07-30].
- • NRR declined to 108% from 111% in Q1, volume-based revenue grew only 3%, and larger deals may require 6-18 months to convert.
Catalyst clock
2026-11-02 · AMC
Q2 results and FY2026 guidance raise
Lead driver: Value · See fundamentals
Momentum
89
8% active weight
Current posture
7d trendSoftening
Δ7d
+0.1
Δ21d
+7.4
Value
60
47% active weight
Current posture
7d trendFlat
Δ7d
+0.6
Δ21d
-0.1
Sentiment
39
45% active weight
Current posture
7d trendSoftening
Δ7d
-3.2
Δ21d
-14.7
Why this grade
Composite grade C. Momentum 88.8 / Value 60.0 / Sentiment 39.3
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-03. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$24.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$5.37B
Beta
-
Shares Out
191.75M
P/E (TTM)
51.4
P/S (TTM)
5.85
P/FCF (TTM)
21.37
Rev YoY
+18.1%
EPS YoY
+18.6%
Gross Margin
+56.1%
Op Margin
+25.4%
Net Debt
$1.39B
Current Ratio
1.85
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data